Section II: Object
II.1)Scope of the procurement
II.1.1)Title:
Dostawa antybiotyków, leków ogólnych, cytostatycznych
Reference number: WCPiT/EA/381-47/2020
II.1.2)Main CPV code33651100 Antibacterials for systemic use
II.1.3)Type of contractSupplies
II.1.4)Short description:
Przedmiotem zamówienia jest dostawa antybiotyków, leków ogólnych, cytostatycznych.
Przedmiot zamówienia został podzielony na 7 pakietów.
Szczegółowy opis przedmiotu zamówienia znajduje się w załączniku nr 2 do SIWZ, który jest jednocześnie Formularzem cenowym.
II.1.5)Estimated total valueValue excluding VAT: 5 047 592.31 PLN
II.1.6)Information about lotsThis contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description
II.2.2)Additional CPV code(s)33651100 Antibacterials for systemic use
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33652000 Antineoplastic and immunomodulating agents
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33652000 Antineoplastic and immunomodulating agents
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33670000 Medicinal products for the respiratory system
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33670000 Medicinal products for the respiratory system
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33612000 Medicinal products for functional gastrointestinal disorders
33621200 Antihaemorrhagics
33622100 Cardiac therapy medicinal products
33690000 Various medicinal products
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
II.2)Description
II.2.2)Additional CPV code(s)33141550 Heparin
II.2.3)Place of performanceNUTS code: PL41 Wielkopolskie
II.2.4)Description of the procurement: II.2.5)Award criteriaCriteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing systemDuration in months: 3
This contract is subject to renewal: no
II.2.10)Information about variantsVariants will be accepted: no
II.2.11)Information about optionsOptions: no
II.2.13)Information about European Union fundsThe procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information
Section III: Legal, economic, financial and technical information
III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registersList and brief description of conditions:
Warunek ten zostanie uznany za spełniony, jeżeli wykonawca wykaże, że posiada zezwolenie na hurtowy obrót lekiem wydane na podstawie ustawy z dnia 6 września 2001 r. Prawo farmaceutyczne (t.j. Dz.U.08.45.271 z późn. zm.).
Zamawiający uzna warunek za spełniony w przypadku wykonawców mających siedzibę lub miejsce zamieszkania poza terytorium Polski, z państw członkowskich Unii Europejskiej, z państw członkowskich Europejskiego Stowarzyszenia Wolnego Handlu (EFTA) – stron umowy o Europejskim Obszarze Gospodarczym oraz osoby zagraniczne z państw niebędących stronami umowy o Europejskim Obszarze Gospodarczym, które mogą korzystać ze swobody przedsiębiorczości na podstawie umów zawartych przez te państwa z Unią Europejską i jej państwami członkowskimi – jeżeli wykażą, że posiadają zezwolenie na hurtowy obrót lekiem wydany przez właściwy organ znajdujący się na terenie Państwa w którym wykonawcy mają siedzibę lub miejsce zamieszkania.
III.2)Conditions related to the contract
III.2.2)Contract performance conditions: Section IV: Procedure
IV.1)Description
IV.1.1)Type of procedureOpen procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.8)Information about the Government Procurement Agreement (GPA)The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.2)Time limit for receipt of tenders or requests to participateDate: 15/01/2021
Local time: 09:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:Polish
IV.2.6)Minimum time frame during which the tenderer must maintain the tenderTender must be valid until: 15/03/2021
IV.2.7)Conditions for opening of tendersDate: 15/01/2021
Local time: 11:00
Place:
Wielkopolskie Centrum Pulmonologii i Torakochirurgii im. Eugenii i Janusza Zeylandów Samodzielny Publiczny Zakład Opieki Zdrowotnej, ul. Szamarzewskiego 62, 60-569 Poznań, POLSKA, w sali konferencyjnej w budynku administracji szpitala.